Trial · NCT03548935
Results by group134
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 134
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Body Weight (%) | Semaglutide 2.4 mg | In-trial observation period | -15.6 | Standard Deviation 10.1 | Percentage point |
| Change in Body Weight (%) | Placebo | In-trial observation period | -2.8 | Standard Deviation 6.5 | Percentage point |
| Change in Body Weight (%) | Semaglutide 2.4 mg | On-treatment observation period | -16.9 | Standard Deviation 9.4 | Percentage point |
| Change in Body Weight (%) | Placebo | On-treatment observation period | -3.1 | Standard Deviation 6.4 | Percentage point |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | In-trial observation period / Yes | 1047 | Participants | |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Placebo | In-trial observation period / Yes | 182 | Participants | |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | In-trial observation period / No | 165 | Participants | |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Placebo | In-trial observation period / No | 395 | Participants | |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | On-treatment observation period / Yes | 978 | Participants | |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Placebo | On-treatment observation period / Yes | 165 | Participants | |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | On-treatment observation period / No | 81 | Participants | |
| Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | Placebo | On-treatment observation period / No | 334 | Participants | |
| Subjects Who Achieve 10 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | Yes | 838 | Participants | |
| Subjects Who Achieve 10 or More Percent Body Weight Reduction (Yes/no) | Placebo | Yes | 69 | Participants | |
| Subjects Who Achieve 10 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | No | 374 | Participants | |
| Subjects Who Achieve 10 or More Percent Body Weight Reduction (Yes/no) | Placebo | No | 508 | Participants | |
| Participants Who Achieve 15 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | Yes | 612 | Participants | |
| Participants Who Achieve 15 or More Percent Body Weight Reduction (Yes/no) | Placebo | Yes | 28 | Participants | |
| Participants Who Achieve 15 or More Percent Body Weight Reduction (Yes/no) | Semaglutide 2.4 mg | No | 600 | Participants | |
| Participants Who Achieve 15 or More Percent Body Weight Reduction (Yes/no) | Placebo | No | 549 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03548935/results